Skip to main content

Table 1 Comparison of baseline characteristics of patients with pulmonary Mycobacterium avium complex disease between the control and levofloxacin (LVFX) groups

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Characteristics Control group (n = 57) VFX group (n = 18)
Gender (male/female) 15/42 1/17
Age (years) 71.0 ± 7.0 64.5 ± 6.5
M.avium/M.intracellulare 51/9 16/2
Culture examination score 1.04 ± 0.38 1.06 ± 0.64
Other medication 35 (61) 11 (61)
   Digestive organ agents 30 (53) 5 (28)
   Respiratory organ agents 15 (26) 6 (33)
   Vitamins 4 ( 7 ) 2 (11)
   Allergic agents 4 ( 7 ) 1 ( 1 )
   Cardiovascular agents 4 ( 7 ) 0 ( 0 )
   Anti-inflammatory agents 3 ( 5 ) 2 (11)
   Hypnotics and sedatives, anxiolytics 3 ( 5 ) 0 ( 0 )
   Miscellaneous 2 ( 4 ) 0 ( 0 )
  1. The results are shown as median ± quartile deviation in age, and mean ± standard deviation in culture examination score. Values in other medication express as number (%) of patients. There was no significant difference for each characteristic between both groups